SNP Genetics Inc. agreed to acquire an additional 0.99% stake in Enzychem Lifesciences Corporation from Capitalworks Investment Co.,Ltd. for KRW 780 million in cash on November 6, 2014. SNP Genetics Inc. will acquire 0.06 million shares and increase its stake to 0.13 million shares. In a related transaction, SNP Genetics Inc. acquired 0.002 million shares in Enzychem Lifesciences Corporation.

Board of Directors of SNP Genetics Inc. made a resolution in favor of the transaction on November 6, 2014. The scheduled acquisition date is November 7, 2014.